2 results
Approved WMOCompleted
Evaluation of the feasibility of sentinel node detection by PET-CT lymphoscintigraphy
Approved WMORecruiting
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD ascompared with placebo in patients with mild AD dementia.